These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 11199950

  • 1. No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study.
    Gamma A, Buck A, Berthold T, Vollenweider FX.
    J Clin Psychopharmacol; 2001 Feb; 21(1):66-71. PubMed ID: 11199950
    [Abstract] [Full Text] [Related]

  • 2. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
    Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A.
    Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
    [Abstract] [Full Text] [Related]

  • 3. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 4. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
    Parrott AC, Lasky J.
    Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
    [Abstract] [Full Text] [Related]

  • 5. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
    Kish SJ, Lerch J, Furukawa Y, Tong J, McCluskey T, Wilkins D, Houle S, Meyer J, Mundo E, Wilson AA, Rusjan PM, Saint-Cyr JA, Guttman M, Collins DL, Shapiro C, Warsh JJ, Boileau I.
    Brain; 2010 Jun; 133(Pt 6):1779-97. PubMed ID: 20483717
    [Abstract] [Full Text] [Related]

  • 6. Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low.
    Curran HV, Travill RA.
    Addiction; 1997 Jul; 92(7):821-31. PubMed ID: 9293041
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence.
    Dafters RI, Duffy F, O'Donnell PJ, Bouquet C.
    Psychopharmacology (Berl); 1999 Jul; 145(1):82-90. PubMed ID: 10445376
    [Abstract] [Full Text] [Related]

  • 11. Cognitive performance amongst recreational users of "ecstasy".
    Rodgers J.
    Psychopharmacology (Berl); 2000 Jul; 151(1):19-24. PubMed ID: 10958112
    [Abstract] [Full Text] [Related]

  • 12. Cognitive performance and serotonergic function in users of ecstasy.
    Verkes RJ, Gijsman HJ, Pieters MS, Schoemaker RC, de Visser S, Kuijpers M, Pennings EJ, de Bruin D, Van de Wijngaart G, Van Gerven JM, Cohen AF.
    Psychopharmacology (Berl); 2001 Jan 01; 153(2):196-202. PubMed ID: 11205419
    [Abstract] [Full Text] [Related]

  • 13. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users.
    Fisk JE, Montgomery C, Murphy PN.
    Exp Clin Psychopharmacol; 2009 Oct 01; 17(5):326-36. PubMed ID: 19803632
    [Abstract] [Full Text] [Related]

  • 14. Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study.
    McCann UD, Mertl M, Eligulashvili V, Ricaurte GA.
    Psychopharmacology (Berl); 1999 Apr 01; 143(4):417-25. PubMed ID: 10367560
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Altered states: the clinical effects of Ecstasy.
    Cole JC, Sumnall HR.
    Pharmacol Ther; 2003 Apr 01; 98(1):35-58. PubMed ID: 12667887
    [Abstract] [Full Text] [Related]

  • 17. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.
    Vegting Y, Reneman L, Booij J.
    Psychopharmacology (Berl); 2016 Oct 01; 233(19-20):3473-501. PubMed ID: 27568200
    [Abstract] [Full Text] [Related]

  • 18. Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender.
    de Win MM, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W.
    Psychopharmacology (Berl); 2004 May 01; 173(3-4):376-82. PubMed ID: 14726997
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.
    Parrott AC, Lees A, Garnham NJ, Jones M, Wesnes K.
    J Psychopharmacol; 1998 May 01; 12(1):79-83. PubMed ID: 9584971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.